awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42348354-631645FB-A02F-40AB-BBD6-A1F09C884431
Q42348354-631645FB-A02F-40AB-BBD6-A1F09C884431
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42348354-631645FB-A02F-40AB-BBD6-A1F09C884431
Common therapeutic target for both cancer and obesity.
P2860
Q42348354-631645FB-A02F-40AB-BBD6-A1F09C884431
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42348354-631645FB-A02F-40AB-BBD6-A1F09C884431
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbec5edb5a3c00119b835b71aba1a8dbbd919b64
P2860
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.